Seyyed Sohrab Rostamkalaei

Seyyed Sohrab Rostamkalaei

Auto-generated profile, based on publicly available information

Seyyed Sohrab Rostamkalaei

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SRSeyyed Sohrab Rostamkalaei
Seyyed Sohrab Rostamkalaei
JAJafar Akbari
Jafar Akbari
MSMajid Saeedi
Majid Saeedi
KMKatayoun Morteza-Semnani
Katayoun Morteza-Semnani
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

1 September 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JAJafar Akbari
Jafar Akbari
MSMajid Saeedi
Majid Saeedi
KMKatayoun Morteza-Semnani
Katayoun Morteza-Semnani
SRSeyyed Sohrab Rostamkalaei
Seyyed Sohrab Rostamkalaei
MAMasoumeh Asadi
Masoumeh Asadi
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

19 September 2015 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
JAJafar Akbari
Jafar Akbari
MSMajid Saeedi
Majid Saeedi
KMKatayoun Morteza-Semnani
Katayoun Morteza-Semnani
HKHamid Reza Kelidari
Hamid Reza Kelidari
FMFarshad Sadegh Moghanlou
Farshad Sadegh Moghanlou
SRSohrab Rostamkolaei
Sohrab Rostamkolaei
The Effect of Tween 20, 60, and 80 on Dissolution Behavior of Sprionolactone in Solid Dispersions Prepared by PEG 6000

11 January 2023 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
SRSeyyed Sohrab Rostamkalaei
Seyyed Sohrab Rostamkalaei
MIMaryam Iman
Maryam Iman
RARamin Ataee
Ramin Ataee
ZBZahra Bahari
Zahra Bahari

2 July 2018 in Gazi Medical Journal
Verified
Journal Article
Open access
PDF file
PTPropolis Tabletinin
Propolis Tabletinin
KBKemoterapiye Bağlı
Kemoterapiye Bağlı
GMGelişen Oral Mukozit
Gelişen Oral Mukozit
ÜEÜzerine Etkisi
Üzerine Etkisi
MSMaede Salehi
Maede Salehi
TMTahereh Molania
Tahereh Molania
Background: Oral mucositis is defined as oral mucosal inflammation in cancer patients that is caused by chemotherapy and/or radiotherapy. Propolis is a natural product produced by bees and has antimicrobial, antioxidant, and anti-inflammatory effects. Therefore, considering the anti-inflammatory properties of Propolis, the aim of this study is to evaluate the efficacy of Propolis tablet on oral mucositis caused by chemotherapy. Materials and Methods: In this randomized, double-blinded, placebo-controlled study, 50 patients were enrolled in the study, and samples were taken from patients on Folfox chemotherapy regimen with colon cancer who were admitted to the Oncology Center of Imam Khomeini Hospital in Sari. The patients were then divided into two groups of 25. The first group received 50 mg Propolis tablets as 2 tablets per day for 21 days and the second group received placebo. All patients were examined by oral medicine specialist after initial examination, weekly and for 3 weeks, and the severity of mucositis was recorded according to WHO criteria. Data analysis was performed in SPSS ver. 22 software using T test and Mann-Whitney and Kruskal-Wallis tests. Results: The age range of the participants in the study was between 26-72 years. In the intervention group 13 women (52%) and 12 men (48%) and in the control group 13 women (52%) and 12 men (48%) participated .In this study, there was a significant difference in the mean of oral mucositis severity in the Propolis group compared to placebo group. In the intervention group, oral mucositis grade was significantly lower in the 2nd and 3rd follow up sessions than in the placebo group (p <0.05). No negative complications were reported by patients. Conclusion: This clinical trial study showed that Propolis tablet could play an important role in preventing and improving the oral mucositis caused by chemotherapy.